MedPath

Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy

Not Applicable
Completed
Conditions
Biliary Colic
Cholecystitis
Interventions
Procedure: Laparoscopic Cholecystectomy
Device: Senhance Assisted Cholecystectomy
Registration Number
NCT03380572
Lead Sponsor
Imperial College London
Brief Summary

The Senhance™ surgical robotic system, previously known as Telelap Alf-X (TransEnterix, Morrisville, NC, USA) has recently become available in the UK. It aims to provide the robotic benefits of greater accuracy, dexterity and control with similar operational costs to traditional laparoscopy.

Patients randomly received either a standard laparoscopic cholecystectomy or the Senhance assisted cholecystectomy based on scheduled surgery date. A prospectively maintained database of the first 20 patients undergoing cholecystectomy with the Senhance Surgical System was retrospectively interrogated and compared to a concurrently treated group of 20 laparoscopically treated patients during the same timeframe.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

ASA I or II Confirmed diagnosis of biliary colic or cholecystitis Normal LFTs

Read More
Exclusion Criteria

Patients unable tor unwilling to consent BMI >40

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Laparoscopic CholecystectomyLaparoscopic CholecystectomyCholecystectomy operation performed using standard laparoscopic instruments
Senhance CholecystectomySenhance Assisted CholecystectomyCholecystectomy operation performed using Senhance robotic system
Primary Outcome Measures
NameTimeMethod
Operative Time1 day
Secondary Outcome Measures
NameTimeMethod
Morbidity Data30 days

Trial Locations

Locations (1)

Imperial College NHS Trust

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath